Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.

View in: PubMed

subject areas

Antibodies, Neutralizing
Antibodies, Viral
Antibody Formation
B-Lymphocytes
Computational Biology
Cross Reactions
Epitope Mapping
Female
Gene Expression Profiling
High-Throughput Nucleotide Sequencing
Host-Pathogen Interactions
Humans
Immunodominant Epitopes
Immunologic Memory
Male
Neutralization Tests
Single-Cell Analysis
Spike Glycoprotein, Coronavirus
Transcriptome

authors with profiles

Maria Lucia Madariaga
Andrzej Joachimiak